Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Phase I trial and preclinical data of ACT using neoantige... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Phase I trial and preclinical data of ACT using neoantigen-reactive TIL for patients with advanced epithelial and ICB-resistant solid cancers
0
Authors
Jara Palomero
32 more
Jara Palomero
•
Vladimir Galvao
30 more
•
Elena Garralda
Published
December 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Immuno-Oncology Technology
Topics
Chemistry
Cancer Oncology
Medicine
Immunology
Internal Medicine
Show all topics
DOI
10.1016/j.iotech.2024.101030
License
CC-BY-NC-ND
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Immuno-Oncology Technology
Topics
Chemistry
Cancer Oncology
Medicine
Immunology
Internal Medicine
Show all topics
DOI
10.1016/j.iotech.2024.101030
License
CC-BY-NC-ND
